Arvind Remedies Profile
Key Indicators
- Authorised Capital ₹ 70.00 Cr
as on 02-05-2024
- Paid Up Capital ₹ 68.13 Cr
as on 02-05-2024
- Company Age 36 Year, 6 Months
- Last Filing with ROC 31 Mar 2017
- Open Charges ₹ 1,526.78 Cr
as on 02-05-2024
- Satisfied Charges ₹ 602.26 Cr
as on 02-05-2024
- Revenue -65.86%
(FY 2017)
- Profit 78.32%
(FY 2017)
- Ebitda 98.08%
(FY 2017)
- Net Worth -15.72%
(FY 2017)
- Total Assets -3.55%
(FY 2017)
About Arvind Remedies
- CIN/LLPIN
L24231TN1988PLC015882
- Company No.
015882
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
17 Jun 1988
- Date of AGM
30 Sep 2017
- Date of Balance Sheet
31 Mar 2017
- Listing Status
Listed
- ROC Code
Roc Chennai
Industry
Company Details
- Location
Tiruvallur, Tamil Nadu, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Arvind Remedies Limited offer?
Arvind Remedies Limited offers a wide range of products and services, including Pharmaceutical Medicine, Essential & Aromatic Oils, Carrier Oil, Pharmaceutical Capsules, Gynecology Instrument, Uterine Manipulator, Pharmaceutical Products, Pharmaceutical Drug.
Who are the key members and board of directors at Arvind Remedies?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Arvind Shah  | Managing Director | 17-Jun-1988 | Current |
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Thinangan Madavyadav | Additional Director | 06-Oct-2015 | Current |
| Chandra Ravindran | Whole-Time Director | 09-Dec-1995 | Current |
Financial Performance of Arvind Remedies.
Arvind Remedies Limited, for the financial year ended 2017, experienced significant reduction in revenue, with a 65.86% decrease. The company also saw a substantial improvement in profitability, with a 78.32% increase in profit. The company's net worth observed a substantial decline by a decrease of 15.72%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Arvind Remedies?
In 2017, Arvind Remedies had a promoter holding of 3.58% and a public holding of 96.42%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
L & T Finance Limited Creation Date: 16 Jul 2014 | ₹8.16 Cr | Open |
Allahabad Bank Creation Date: 03 Mar 2012 | ₹705.24 Cr | Open |
Idbi Bank Limited Creation Date: 28 Jun 2010 | ₹6.75 Cr | Open |
How Many Employees Work at Arvind Remedies?
Arvind Remedies has a workforce of 0 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Arvind Remedies, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Arvind Remedies's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
